IL6 and neoplasm: Myeloid-derived suppressor cells (MDSCs) can activate the Notch signaling in tumor cells through the secretion of interleukin-6 (IL-6) [63], and the activation of Notch in tumor cells can impact the recruitment of immune cells [64, 65].